Norway· NO-ID_7E9F644B-F13C-4886-9AD7-98A6A4F46484

Velbe

A vinblastine product containing vinblastine sulfate, registered in Norway by Stada. The same ATC class is registered in 14 of our 19 countries.

ATC L01CA01

Checked against FEST (Norway) on

Informational only — not a medical device.

SOURCE REGISTER · NOFEST (Norway)normalisedVelbeATCL01CA01REGISTER NO.NO-ID_7E9F644B-F13C-4…PACKS LISTED3CHECKEDSeptember 25, 2026

Where it is registered

Vinblastine is registered in 14 of 19 countries.

Countries holding a registration under ATC L01CA01 (vinblastine), each read from that country’s own register.

  • This record: Norway, from FEST (Norway)
  • 8 of them publish a price we can compare per daily dose

Vinblastine · ATC L01CA01

14 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Ireland
  • Netherlands
  • Norwayprice
  • Spainprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of vinblastine costs, country by country.

Normalised to the WHO defined daily dose (11.61 mg), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Vinblastine · price per daily dose (11.61 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$56.28
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

FEST (Norway)
Active substance
Vinblastine Sulfate
Manufacturer
Stada
Country
Norway (NO)
ATC code
L01CA01
ATC class
Vinblastine
Defined daily dose
11.61 mg, P
Reimbursed
Not published by this register
Source register
FEST (Norway)
Last checked
September 25, 2026

Packs & prices · 3

  • no_merkevare_id
    ID_7E9F644B-F13C-4886-9AD7-98A6A4F46484
  • no_varenummer
    259455
    10
  • gtin
    9088880149232

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

416 interactions on record for vinblastine.

Graded by severity as the source publishes them — 61 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Vinblastine · interactions on record

416 records

  • 61 severe
  • 303 moderate
  • 24 minor
  • 28 info

Most severe, free to view

  • LonafarnibA16AX20severe
  • ConivaptanC03XA02severe
  • KetoconazoleH02CA03severe
  • ErythromycinJ01FA01severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Vinblastine in 13 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All vinblastine products

Authorised across Europe · EMA

The same active substance is authorised in 20 EEA countries. Names it is sold under:

  • Austria · Velbe
  • Belgium · Vinblastine Teva
  • Czechia · Vinblastin Teva
  • Germany · Vinblastin Stada, Vinblastinsulfat Teva
  • Denmark · Velbe
  • Estonia · Vinblastine Teva
  • Spain · Vinblastina Stada
  • Finland · Velbe
  • France · Velbe
  • United Kingdom (Northern Ireland) · Vinblastine Sulfate Hospira Uk
  • Ireland · Vinblastine Sulfate Pfizer Healthcare Ireland
  • Italy · Velbe
  • Lithuania · Vinblastine Teva
  • Luxembourg · Vinblastine Teva
  • Latvia · Vinblastine Teva
  • Malta · Vinblastine Sulfate Pfizer Hellas
  • Netherlands · Vinblastinesulfaat Pch
  • Portugal · Solblastin
  • Romania · Vinblastină Teva
  • Sweden · Velbe

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FEST (Norway). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/5f0217a1-5253-4bc5-b19d-d6e0342c3b18
GET /v1/drugs/5f0217a1-5253-4bc5-b19d-d6e0342c3b18?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Pulver til injeksjonsvæske, oppløsning",
  "source": "fest",
  "status": "A",
  "atc_name": "Vinblastin",
  "merkevare_id": "ID_7E9F644B-F13C-4886-9AD7-98A6A4F46484",
  "name_form_strength": "Velbe pulv til inj væske, oppl 10 mg",
  "prescription_group": "C"
}

See everything about vinblastine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.